The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Drug use in children: cohort study in three European countries
Open accessAbstract
OBJECTIVE: To provide an overview of drug use in children in three European countries. DESIGN: Retrospective cohort study, 2000-5. SETTING: Primary care research databases in the Netherlands (IPCI), United Kingdom (IMS-DA), and Italy (Pedianet). PARTICIPANTS: 675 868 children aged up to 14 (Italy) or 18 (UK and Netherlands). MAIN OUTCOME MEASURE: Prevalence of use per year calculated by drug class (anatomical and therapeutic). Prevalence of "recurrent/chronic" use (three or more prescriptions a year) and "non-recurrent" or "acute" use (less than three prescriptions a year) within each therapeutic class. Descriptions of the top five most commonly used drugs evaluated for off label status within each anatomical class. RESULTS: Three levels of drug use could be distinguished in the study population: high (>10/100 children per year), moderate (1-10/100 children per year), and low (<1/100 children per year). For all age categories, anti-infective, dermatological, and respiratory drugs were in the high use group, whereas cardiovascular and antineoplastic drugs were always in the low use group. Emollients, topical steroids, and asthma drugs had the highest prevalence of recurrent use, but relative use of low prevalence drugs was more often recurrent than acute. In the top five highest prevalence drugs topical inhaled and systemic steroids, oral contraceptives, and topical or systemic antifungal drugs were most commonly used off label. CONCLUSION: This overview of outpatient paediatric prescription patterns in a large European population could provide information to prioritise paediatric therapeutic research needs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A literature review on off-label drug use in children
Pandolfini, C., & Bonati, M. (2005) · European Journal of Pediatrics · doi:10.1007/s00431-005-1698-8 · Cited by 346 · cited 1×
“Recent years have seen growing concerns about the incompleteness of the evidence relating to the efficacy and safety of drugs used in children. Almost all of the drugs prescribed to children are the same as those originally developed for adults. They are often prescribed on an unlicensed or “off label” basis (percenta…”
BackgroundOver the counter but no longer under the radar - pediatric cough and cold medications
Sharfstein, J. M., North, M., & Serwint, J. R. (2007) · New England Journal of Medicine · doi:10.1056/nejmp0707400 · Cited by 158 · cited 1×
“Another example underlining the need for education rather than research is the cough and cold medications. These drugs are not only available over the counter but are also often prescribed, which should be strongly discouraged because of reports of death and lack of efficacy.”
Background
Cited by
Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children
Korpela, K., Salonen, A., Virta, L. J., Kekkonen, R. A., Forslund, K., Bork, P., & de Vos, W. M. (2016) · Nature Communications · doi:10.1038/ncomms10410 · Cited by 698
Antibiotics in early life: dysbiosis and the damage done
Neuman, H., Forsythe, P., Uzan, A., Avni, O., & Koren, O. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy018 · Cited by 259
Aagaard, L., Weber, C. B., & Hansen, E. H. (2010) · Drug Safety · doi:10.2165/11319100-000000000-00000 · Cited by 75
Stanisavljević, S., Čepić, A., Bojić, S., Veljović, K., Mihajlović, S., Đedović, N., Jevtić, B., Momčilović, M., Lazarević, M., Mostarica Stojković, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37505-7 · Cited by 43
Osokogu, O. U., Fregonese, F., Ferrajolo, C., Verhamme, K., de Bie, S., Jong, G. ’., Catapano, M., Weibel, D., Kaguelidou, F., Bramer, W. M., et al. (2015) · Drug Safety · doi:10.1007/s40264-015-0265-0 · Cited by 31
Self-citation
Metadata
- Authors
- Sturkenboom, M. C. J. M., Verhamme, K. M. C., Nicolosi, A., Murray, M. L., Neubert, A., Caudri, D., Picelli, G., Sen, E. F., Giaquinto, C., Cantarutti, L., Baiardi, P., Felisi, M.-G., Ceci, A., Wong, I. C. K., & on behalf of the TEDDY European Network of Excellence
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2008-11-24
- Volume
- 337
- Issue
- nov24 2
- Pages
- a2245-a2245
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2147291501
- Cited by
- 234
- References
- 2
- FWCI
- 11.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.